openPR Logo
Press release

Global Allergic Rhinitis Market Dynamics and Development By FAES Farma SA; Hisamitsu Pharmaceutical Co.,Inc.; Glenmark Pharmaceuticals; Olainfarm

01-10-2020 10:58 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Allergic Rhinitis Market

Global Allergic Rhinitis Market

Global allergic rhinitis market is expected to rise to an estimated value of USD 10.54 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the innovations in product development and offerings which have resulted in marketing of drugs which not only treat the symptoms but rather the cause itself.

This allergic rhinitis research report forecast 2019-2026 is a valuable source of insightful data of business strategists. It provides the industry overview with growth analysis and historical and futuristic cost, revenue, demand and supply data. The report presents market competitive landscape and a corresponding detailed analysis of the major vendor/ key players in the market.

Get Sample Copy Of This Report @

Few of the major competitors currently working in the global allergic rhinitis market are Merck KGaA; GSK group of companies; Sanofi; Cigna; Himalaya Wellness; Janssen Global Services, LLC; FAES Farma SA; Hisamitsu Pharmaceutical Co.,Inc.; Glenmark Pharmaceuticals; Olainfarm; Boehringer Ingelheim International GmbH; Covis Pharma; Teva Pharmaceutical Industries Ltd.; Sandoz International GmbH; ALK and Meda among others.

Key Developments in the Market:

In June 2019, ALK announced that they had finalized the marketing authorization for their tree sublingual allergy immunotherapy (SLIT) tablets, with the brand name to be expected as “ITULAZAX”. The authorization has been completed for seventeen of the countries for the European region for the treatment of allergic rhinitis. This approval will provide patients suffering from the disease a better quality of life targeting the cause of the diseases and not just treating the symptoms associated with it
In May 2019, Glenmark Pharmaceuticals announced that they had received positive conclusive evidence from their Phase 3 study of “Ryaltris”, designed for the treatment of seasonal allergic rhinitis by acting as a fixed-dose nasal spray. The study was conducted for patients aged between six and twelve, and it met the primary endpoint set forth meaning the clinical efficiency for the drug was achieved. The product depending on the approval is set to be commercialized by Glenmark Pharmaceuticals’ subsidiary “Glenmark Therapeutics Inc. USA

Inquiry For Customize Report With Discount at :

Segmentation: Global Allergic Rhinitis Market

By Type
(Seasonal, Perennial, Occupational Rhinitis),

(Immunotherapy, Antihistamines, Decongestants, Vertebral Fusion, Corticosteroids, Others),

Route of Administration
(Oral, Parenteral, Intranasal),

(Solid, Liquid),

(Skin Test, IgE RAST Test, Complete Blood Count),

(North America, Europe, Asia-Pacific, South America, Middle East and Africa)

Market Drivers

Increasing demand for easy to administer drugs and methods is expected to boost the growth of the market
Growing levels of strategies and collaborative practices undertaken by various manufacturers to focus on better delivery of treatment is also expected to augment growth of the market
Availability of highly-efficient workforce and resources for the efficient development and commercialization of products is also expected to boost the growth of the market
Increasing prevalence of the diseases caused by a rise in the population consuming tobacco
Market Restraints

High levels of presence in competition from generic drugs for the disease as major patents are on the verge of expiration is expected to restrict the growth of the market
Availability and increased adoption of alternative treatment modes is also expected to restrict the growth of the market

Get Detailed TOC @

Data Bridge Market Research
Tel: +1-888-387-2818

About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Allergic Rhinitis Market Dynamics and Development By FAES Farma SA; Hisamitsu Pharmaceutical Co.,Inc.; Glenmark Pharmaceuticals; Olainfarm here

News-ID: 1893651 • Views: 511

More Releases from Data Bridge Market Research

Electronic Drug Delivery Systems Industry - A Market Worth Observing Growth | Ca …
Global electronic drug delivery systems market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 15.31 Billion by 2027 growing at a CAGR of 8.8% in the above-mentioned forecast period. The growth of this market is owing to multiple factors such as rise in prevalence of diseases, technological advancement in the design of electronic
Electroencephalography Devices Market Excellent Growth By 2026| Natus Medical In …
Global Electroencephalography Devices Market Research Report: By Product Type (MRI, CT, PET, EEG, EMG, MEG, TCD, ICP, Electrodes, Sensors, Gels, Cables), Application (Diagnostics, Therapeutics), Procedure (Invasive, Non-Invasive), Disease (TBI, Stroke, Dementia, Epilepsy),Indication(Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Patent Foramen Ovale (PFO), Aortic Valve Stenosis, Others), Device Type (8-Channel EEG, 21-Channel EEG, 32-Channel EEG, 64-Channel EEG, Others), Modality (Standalone, Portable), End-Users (Hospitals, Clinics, Diagnostic Centers), Geography (North America, Europe,
DevOps Market May Set New Growth Story | CA Technologies, IBM Corp., Puppet Inc. …
Data Bridge Market Research recently published a research report titled, "DevOps Market Report, History and Forecast to 2026, Breakdown Data by Manufacturers, Key Regions, Types and Application". The research report attempts to give a holistic overview of the DevOps Market by keeping the information simple, relevant, accurate, and to the point. The researchers have explained each aspect of the market thorough meticulous research and undivided attention to every topic. They
Global RFID Market Growing at a CAGR of 11.72% | Honeywell International Inc, HI …
Inclusive Insight: Global RFID Market Global RFID market is to register a healthy CAGR of 11.72% in the forecast period of 2019-2026.? RFID is an acronym for "radio frequency identification" and relates to a technique in which digital data embedded in RFID tags or smart tags is discovered by a viewer via radio waves. RFID is identical to barcoding in that the tag or label data is detected by a machine

All 5 Releases

More Releases for Rhinitis

Global Allergic Rhinitis Drugs Market Data Survey Report 2025
Global Allergic Rhinitis Drugs Market 2019 alongside scientific information of driving variables of industry, contemporary market patterns, sections, applications, and types, and additionally district shrewd investigation is ingrained in the Global Allergic Rhinitis Drugs Market Report. Basically the report focuses over the propensity of the Allergic Rhinitis Drugs advertise and deciphers its job in the global economy. The Allergic Rhinitis Drugs advertise report comprises a fundamentals information in regards to
Allergic Rhinitis Drugs Market Report By CMI
Introduction of new drugs is expected to drive growth of the market Manufacturers are developing a variety of drugs and nasal sprays for the treatment of allergic rhinitis. This in turn, is expected to fuel growth of the allergic rhinitis drugs market in the near future. For instance, in March 2017, the U.S. Food and Drug Administration (FDA) approved Odactra drug, manufactured by Catalent Pharma Solutions Limited, the first allergen
Allergic Rhinitis Market 2018 by Seasonal, Perennial and Non Allergic Rhinitis T …
The Allergic Rhinitis Market is segmented into types, by treatment and by test. The types of the allergic rhinitis includes seasonal, perennial and non-allergic rhinitis. On the basis of the treatment the segmentation is done into antihistamines, decongestants, eye drops, nasal sprays, immunotherapy, sublingual immunotherapy (SLIT) and home remedies. The antihistamine segment is further sub-segmented into drugs like allegra, clarinex, xyzal and zyrtec. The decongestants segment is also sub-segmented into
Global Allergy Rhinitis Drugs Industrial and Market studies 2017-2021
"Global Allergy Rhinitis Drugs Market 2017-2021" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Allergic rhinitis refers to the inflammation of nasal membranes that causes nasal congestion, sneezing, itching, and rhinorrhea. This condition is usually caused by dust, animal dander, pollen, and certain food ingredients. Allergic rhinitis or hay fever occurs when the immune system overreacts to allergens in the air such as dust,
Global Allergic Rhinitis Market Research Report - Pipeline Review, H2 2017
"The Latest Research Report Allergic Rhinitis-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" About Allergic Rhinitis Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis-Pipeline Review, H2 2017, provides an overview of the Allergic Rhinitis (Respiratory) pipeline landscape. Allergic rhinitis is an allergic reaction that happens when immune system overreacts to substances that is inhaled.
Seasonal Allergic Rhinitis Pipeline Insight: Pharmaceutical and Healthcare Repor …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Seasonal Allergic Rhinitis-Pipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Seasonal Allergic Rhinitis. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Seasonal Allergic Rhinitis by development stage, therapy